Search
Precipio Inc
PRPOAdd to Watchlist
25.260USD
+0.330+1.32%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
44.99MMarket Cap
LossP/E TTM
More Details of Precipio Inc Company
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Precipio Inc Info
Ticker SymbolPRPO
Company namePrecipio Inc
IPO dateJul 18, 2000
CEODanieli (Ilan S)
Number of employees54
Security typeOrdinary Share
Fiscal year-endJul 18
Address4 Science Park
CityNEW HAVEN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code06511
Phone12037877888
Websitehttps://www.precipiodx.com/
Ticker SymbolPRPO
IPO dateJul 18, 2000
CEODanieli (Ilan S)
Company Executives of Precipio Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Ilan S. Danieli
Mr. Ilan S. Danieli
Chief Executive Officer, Founder, Director
Chief Executive Officer, Founder, Director
--
--
Dr. Jeffrey Cossman, M.D.
Dr. Jeffrey Cossman, M.D.
Independent Director
Independent Director
--
--
Mr. David S. Cohen
Mr. David S. Cohen
Independent Director
Independent Director
--
--
Ms. Kathleen D. Laporte
Ms. Kathleen D. Laporte
Independent Director
Independent Director
--
--
Dick Sandberg ,
Dick Sandberg ,
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Ahmed Zaki Sabet
Mr. Ahmed Zaki Sabet
Chief Operations Officer
Chief Operations Officer
--
--
Mr. Ronald A. (Ron) Andrews, Jr.
Mr. Ronald A. (Ron) Andrews, Jr.
Independent Director
Independent Director
--
--
Dr. Ayman A. Mohamed, M.D.
Dr. Ayman A. Mohamed, M.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Matthew Gage
Mr. Matthew Gage
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Christina R. Valauri
Ms. Christina R. Valauri
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Ilan S. Danieli
Mr. Ilan S. Danieli
Chief Executive Officer, Founder, Director
Chief Executive Officer, Founder, Director
--
--
Dr. Jeffrey Cossman, M.D.
Dr. Jeffrey Cossman, M.D.
Independent Director
Independent Director
--
--
Mr. David S. Cohen
Mr. David S. Cohen
Independent Director
Independent Director
--
--
Ms. Kathleen D. Laporte
Ms. Kathleen D. Laporte
Independent Director
Independent Director
--
--
Dick Sandberg ,
Dick Sandberg ,
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Ahmed Zaki Sabet
Mr. Ahmed Zaki Sabet
Chief Operations Officer
Chief Operations Officer
--
--
FAQs
Who are the top five shareholders of Precipio Inc?
The top five shareholders of Precipio Inc are: Mr. Ilan S. Danieli
How many institutions hold shares of Precipio Inc (PRPO)?
As of 2026Q1, 30 institutions hold shares of Precipio Inc, with a combined market value of approximately 341.74K, accounting for 19.15% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -28788.00.
What is the biggest source of revenue for Precipio Inc?
In 2026Q1, the Third party payers business generated the highest revenue for Precipio Inc, amounting to 11.70M and accounting for 48.26% of total revenue.